The UK Prospective Diabetes Study

Annals of Medicine

Volumn 28, Issue 5, 1996, Pages 439-444

  Turner, Robert C ^a   Holman, Rury R ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Blood glucose control; Cardiovascular complications; Non insulin dependent diabetes mellitus; Randomized controlled trial

Indexed keywords

GLUCOSE; INSULIN; METFORMIN; SULFONYLUREA;

ARTICLE; CARDIOVASCULAR DISEASE; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC ANGIOPATHY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; HYPOGLYCEMIA; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 0029840022     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899608999105     Document Type: Article

References (21)

1. UKPDS Group. UK Prospective Diabetes Study VIII: study design, progress and performance. Diabetologia 1991; 34: 877-90.
2. Garcia MJ, McNamara PM, Gordon T, Kannell WB. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up. Diabetes 1974; 23: 105-11.
3. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12 year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434-44.
4. Panzram G. Mortality and survival in Type 2 (non-insulin-dependent) diabetes mellitus. Diabetelogia 1987; 30: 123-31.
5. Laing W, Williams DR. Diabetes, a Model for Health Care Management. London: Office of Health Economics, 1989.
6. Knatterud GL, Klimt CR, Levin ME, Jacobson ME, Goldner MG. Effects of hypoglycaemic agents on vascular complications in patients with adult-onset diabetes. VII. Mortality and selected nonfatal events with insulin treatment. JAMA 1978; 240: 37-42.
7. Jarrett RJ, Keen H. Hyperglycaemia and diabetes mellitus. Lancet 1976; 2: 1009-12.
8. Pettitt DJ, Knowler WC, Lisse JR, Bennett PH. Development of retinopathy and proteinuria in relation to plasma glucose concentration in Pima Indians. Lancet 1980; 2: 1050-2.
9. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall Study. Lancet 1980; 1: 1373-6.
10. Eschwège E, Richard JL, Thibult N, et al. Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris Prospective Study, ten years later. Horm Metab Res Suppl 1985; 15: 41-6.
11. Walters DP, Gatling W, Houston AC, Mullee MA, Julious SA, Hill RD. Mortality in diabetic subjects: an eleven-year follow-up of a community-based population. Diabet Med 1994; 11: 968-73.
12. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 1994; 43: 960-7.
13. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86.
14. Meinart CL, Knatterud GL, Prout TE, Klimt CR. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. 2. Mortality results. Diabetes 1970; 19 (Suppl 2): 789-830.
15. University Group Diabetes Programme. A study of the effects of hypoglycaemic agents on vascular complications on patients with adult-onset diabetes. V. Evaluation of phenformin therapy. Diabetes 1975; 24 (Suppl 1): 65-184.
16. Stout RW. Insulin and atherosclerosis. In: Stout RW, ed. Diabetes and Atherosclerosis. Dordrecht: Kluwer Academic Publishers, 1992: 165-201.
17. UKPDS Group. UK Prospective Diabetes Study XII: Differences between Asian, Afro-Caribbean and white Caucasian type 2 diabetic patients at diagnosis of diabetes. Diabet Med 1994; 11: 670-7.
18. UKPDS Group. UK Prospective Diabetes Study 16: Overview of six years' therapy of type 2 diabetes - a progressive disease. Diabetes 1995; 44: 1249-58.
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985; 28: 412-9.
20. Hypertension in Diabetes Study Group. HDS 2: increased risk of cardio-vascular complications in hypertensive type 2 diabetic patients. J Hypertens 1993; 11: 319-25.
21. Hypertension in Diabetes Study Group. HDS 3: prospective study of therapy in type 2 diabetic patients - Efficacy of ACE inhibitor and β-blocker. Diabet Med 1994; 11: 773-82.